To investigate whether FADS1 inhibition affects tumor cell proliferation, we performed immunofluorescence staining of proliferation marker Ki-67 in 786-o and A498 cells treated with increasing concentrations of the FADS1 inhibitor for 96 h. Here, MKI67 is linked to neoplasm.